OSAIC HOLDINGS, INC. - CHINA BIOLOGIC PRODS HLDGS I ownership

Quarter-by-quarter ownership
OSAIC HOLDINGS, INC. ownership history of CHINA BIOLOGIC PRODS HLDGS I
ValueSharesWeighting
Q1 2021$10,000
+11.1%
83
+12.2%
0.00%
Q4 2020$9,000
-52.6%
74
-57.0%
0.00%
Q3 2020$19,000
+11.8%
172
+6.8%
0.00%
Q2 2020$17,000
-62.2%
161
-60.2%
0.00%
Q1 2020$45,0004050.00%
Other shareholders
CHINA BIOLOGIC PRODS HLDGS I shareholders Q3 2023
NameSharesValueWeighting ↓
VERNIER CAPITAL PARTNERS, LP 131,657$13,077,0005.92%
Point72 Hong Kong Ltd 103,797$10,310,0003.49%
York Capital Management Global Advisors, LLC 827,738$82,219,0002.00%
Parametrica Management Ltd 3,889$386,0001.83%
Athos Capital Ltd 35,266$3,503,0001.19%
Hillhouse Capital Management 618,391$61,425,0001.05%
JUPITER ASSET MANAGEMENT LTD 502,812$49,940,0000.73%
Black Creek Investment Management Inc. 240,232$23,862,0000.73%
COMGEST GLOBAL INVESTORS S.A.S. 243,652$24,202,0000.54%
Temasek Holdings (Private) Ltd 990,000$98,337,0000.52%
View complete list of CHINA BIOLOGIC PRODS HLDGS I shareholders